On Tuesday, Biotech company Bluebird suspended its trials of gene therapy as a treatment for blood-related disorders over concerns of a…
Gene therapies are very much at their preliminary stages of development, so it would make sense to keep tabs on…
Aaron Traywick, the theatrical CEO of a regulation-averse biotech company called Ascendance Biomedical who recently injected himself with an untested…
Username or Email Address
Yes, I wish to receive exclusive discounts, special offers and competitions from our partners.
Now you can get the top stories from Gizmodo delivered to your inbox. Enter your email below.